Non-adherence has historically been blamed on the patients themselves. However, a broad industry shift towards patient centricity and a great appreciation of the behavioural barriers means that the focus of responsibility is shifting to healthcare practioners, the government and pharmaceutical companies.
Patient’s automatic decision-making processes exert a strong influence on behaviour and therefore understanding the personal and situational barriers in the use of medication is crucial to combat the adherence problem effectively.
Our paper provides a framework for thinking about adherence through patient behaviour, looking at four categories: motivation, ability, physical context and social context. These are overlaid with the three stages of adherence to give a holistic understanding of the problem at hand.
With this framework, we can begin to create bespoke interventions which speak to individuals, allowing a patient-centric and more informed approach to tackling the adherence challenge.
The link below will take you to the full report
Improving the care experience of patients with Alzheimer’s and dementia during the COVID-19 pandemic and beyond
Laura Thomas and Jenny Brooks look at data from a 2020 survey conducted for the Care Quality Commission to understand the inpatient experience of those with Alzheimer’s or dementia during the COVID-19 pandemic.
The Future of Fats, Sugar and the Obesity Crisis
This fascinating report looks at expert opinion among regulators, academics, clinicians and food producers, as well as public opinion to chart what may happen next in terms of sugar and fat in our diets, and what it might mean for the obesity crisis. This global study of more than 20,000 people across 30 countries incorporates the expert analysis of 70 healthcare and nutrition experts.